Is Lowering PD-L1 Threshold for Pembrolizumab a Good Idea? Is Lowering PD-L1 Threshold for Pembrolizumab a Good Idea?

What is the best treatment option for patients with advanced NSCLC and PD-L1 of 1-49% on tumor cells?Translational Lung Cancer Research
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news